6-39026654-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_001206927.2(DNAH8):c.13823C>T(p.Thr4608Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000273 in 1,613,320 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001206927.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH8 | NM_001206927.2 | c.13823C>T | p.Thr4608Met | missense_variant | 92/93 | ENST00000327475.11 | NP_001193856.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH8 | ENST00000327475.11 | c.13823C>T | p.Thr4608Met | missense_variant | 92/93 | 5 | NM_001206927.2 | ENSP00000333363 | P2 | |
DNAH8 | ENST00000359357.7 | c.13172C>T | p.Thr4391Met | missense_variant | 90/91 | 2 | ENSP00000352312 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00156 AC: 238AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000431 AC: 108AN: 250390Hom.: 0 AF XY: 0.000310 AC XY: 42AN XY: 135274
GnomAD4 exome AF: 0.000136 AC: 198AN: 1461074Hom.: 0 Cov.: 31 AF XY: 0.000113 AC XY: 82AN XY: 726762
GnomAD4 genome AF: 0.00160 AC: 243AN: 152246Hom.: 1 Cov.: 33 AF XY: 0.00165 AC XY: 123AN XY: 74436
ClinVar
Submissions by phenotype
Spermatogenic failure 46 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 23, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 05, 2021 | - - |
Primary ciliary dyskinesia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at